AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$4.42
-0.57 (-11.42%)
Open$4.86
Previous Close$4.99
Day High$4.91
Day Low$4.32
52W High$7.55
52W Low$2.93
Volume—
Avg Volume1.64M
Market Cap590.87M
P/E Ratio—
EPS$-0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+486.0% upside
Current
$4.42
$4.42
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.46M | 55.71M | 128.94M |
| Net Income | -102,434,906 | -94,303,820 | 33.13M |
| Profit Margin | -188.1% | -178.7% | 25.7% |
| EBITDA | -86,199,052 | -83,765,445 | 53.66M |
| Free Cash Flow | — | — | 23.71M |
| Rev Growth | -2.2% | -2.2% | +19.1% |
| Debt/Equity | 4.68 | 4.68 | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |